Recent Drug Discovery Research for December 2024
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Chondrosarcoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Oncology/Hematology
| Neuroblastoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology, Oncology/Hematology
| Gallbladder Cancer (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
Regions: Global
| Endometrial Cancer (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
| Vaginal Cancer (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
| Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Drugs in Development, 2021
Topics: Drug Development, Coagulation, Drug Discovery
| Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery
| Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Drugs in Development, 2021
Topics: Enzymes, Drug Development, Drug Discovery
| Ageing (Other Diseases) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gerontology/Aging
| Hypoglycemia - Epidemiology Forecast to 2030
Topics: Diabetes, Research & Development, Drug Discovery
| Hypoglycemia - Global Drug Forecast and Market Analysis to 2030
Topics: Diabetes, Research & Development, Drug Discovery
Regions: Global
| Axillary Hyperhidrosis - Opportunity Assessment and Forecast to 2030
Topics: Research & Development, Drug Discovery
| Gastrointestinal Stromal Tumor (GIST) (Oncology) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, Oncology/Hematology, Gastrointestinal
| Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, Ophthalmology
| Encephalopathy (Central Nervous System) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology
| Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology
| Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021
Topics: Multiple Sclerosis (MS), Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology
| Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology
| Bullous Pemphigoid (Dermatology) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, Dermatology
| Liver Failure (Hepatic Insufficiency) (Gastrointestinal) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, Gastrointestinal
| Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, Gastrointestinal
| Ornithine-Transcarbamylase Deficiency - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery
| Gaucher Disease - Drugs in Development, 2021
Topics: Gaucher's, Research & Development, Prescription Drugs, Drug Discovery
| Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery
| Usher Syndrome - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery
| Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery
| Anemia in Chronic Kidney Disease (Renal Anemia) (Hematology) - Drugs in Development, 2021
Topics: Blood Diseases, Research & Development, Prescription Drugs, Drug Discovery, Oncology/Hematology, Renal
| Heart Transplant Rejection (Immunology) - Drugs in Development, 2021
Topics: Blood Supply, Tissue Banking, Transplantation, Research & Development, Prescription Drugs, Drug Discovery, Cardiovascular
| RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Prescription Drugs, Drug Discovery
| Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
| Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
| Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
| 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
| Prostate Cancer (Oncology) - Drugs in Development, 2021
Topics: Cancer Treatment, Research & Development, Prescription Drugs, Drug Discovery, Oncology/Hematology, Men's Health
| Melanoma (Oncology) - Drugs in Development, 2021
Topics: Cancer Treatment, Research & Development, Prescription Drugs, Drug Discovery, Oncology/Hematology
| Myelodysplastic Syndrome (Oncology) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, Oncology/Hematology
| Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021
Topics: Hospitals & Clinics, Drug Discovery, Infectious Diseases
| Tinea Pedis (Athlete Foot) (Infectious Disease) - Drugs in Development, 2021
Topics: Drug Discovery, Infectious Diseases, Dermatology
| Toxoplasmosis (Infectious Disease) - Drugs in Development, 2021
Topics: Drug Discovery, Infectious Diseases
| Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021
Topics: Drug Discovery, Respiratory/Pulmonary
Regions: Middle East
| Dengue Fever (Infectious Disease) - Drugs in Development, 2021
Topics: Dengue, Research & Development, Drug Discovery
| Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021
Topics: Influenza, Drug Discovery, Infectious Diseases
| Western Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021
Topics: Livestock, Veterinary Health, Drug Discovery, Infectious Diseases
| Hyperglycemia (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Discovery
| Prosthetic joint infections (Musculoskeletal) - Drugs in Development, 2021
Topics: Drug Discovery, Orthopedics
|
Prev | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
